07524498 is referenced by 7 patents and cites 11 patents.

The present invention provides to a humanized monoclonal antibody having immunostimulatory effects. This antibody binds specifically to B lymphoblastoid cells, induces proliferation and activation of peripheral blood lymphocytes, particularly T cells, and is capable of eliciting an anti-tumor effect upon administration to subjects suffering from cancer.

Title
Human immunomodulatory monoclonal antibodies for the treatment of cancer
Application Number
11/854160
Publication Number
7524498 (B2)
Application Date
September 12, 2007
Publication Date
April 28, 2009
Inventor
Leah Klapper
Givataim
IL
Steven Tarran Jones
Radlett
GB
Britta Hardy
Tel Aviv
IL
Agent
Winston & Strawn
Assignee
Mor Research Application
IL
CureTech
IL
IPC
G01N 33/574
C07H 21/04
C07K 16/00
C12N 5/06
C12P 21/08
C12P 21/04
A61K 39/395
View Original Source